Pharmacy Usual Items - Bangladesh

  • Bangladesh
  • Revenue in the Pharmacy Usual Items market is projected to reach US$2.39bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.44%, resulting in a market volume of US$2.97bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$13.69 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Bangladesh has been experiencing significant growth in recent years. Customer preferences have shifted towards a greater demand for over-the-counter medications and personal care products. This trend can be attributed to several factors, including increased healthcare awareness, changing lifestyles, and a growing middle class. Additionally, local special circumstances such as a lack of access to healthcare facilities and a high prevalence of self-medication have contributed to the growth of the market.

Customer preferences:
Customers in Bangladesh have shown a preference for over-the-counter medications and personal care products due to several reasons. Firstly, there has been a rise in healthcare awareness among the population, leading to increased demand for self-medication options. Consumers are becoming more proactive in managing their health and are seeking easily accessible remedies for common ailments. Secondly, changing lifestyles, such as longer working hours and increased stress levels, have resulted in a higher incidence of minor health issues. As a result, individuals are opting for convenient and quick solutions available at pharmacies. Lastly, the growing middle class in Bangladesh has led to an increase in disposable income, enabling consumers to spend more on healthcare products.

Trends in the market:
One of the key trends in the Pharmacy Usual Items market in Bangladesh is the growing popularity of generic medications. Generic drugs offer the same therapeutic benefits as branded drugs but at a lower cost. This has made them a preferred choice among price-conscious consumers. Pharmacies are increasingly stocking a wide range of generic medications to cater to this demand. Another trend is the expansion of pharmacy chains across the country. These chains offer a one-stop solution for customers, providing a wide range of products and services, including prescription medications, over-the-counter drugs, personal care products, and health consultations. The presence of pharmacy chains has made healthcare more accessible to the population, particularly in rural areas where access to healthcare facilities may be limited.

Local special circumstances:
Bangladesh faces unique challenges in terms of healthcare access and affordability. Many people in rural areas do not have easy access to healthcare facilities, and even when they do, the cost of medical consultations and prescription medications can be prohibitive. As a result, self-medication is prevalent in the country, with individuals relying on over-the-counter medications for common ailments. This has created a significant market opportunity for pharmacies, as they provide a convenient and affordable alternative to traditional healthcare services.

Underlying macroeconomic factors:
Several macroeconomic factors have contributed to the growth of the Pharmacy Usual Items market in Bangladesh. Firstly, the country has experienced steady economic growth in recent years, resulting in an increase in disposable income. This has allowed consumers to spend more on healthcare products and services. Secondly, the population of Bangladesh is growing rapidly, leading to an increased demand for healthcare products. Additionally, the government has taken steps to improve healthcare infrastructure and access to medicines, further driving the growth of the market. Overall, the Pharmacy Usual Items market in Bangladesh is expected to continue its upward trajectory in the coming years, driven by changing customer preferences, local special circumstances, and favorable macroeconomic factors.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)